α-synuclein and the pathogenesis of Parkinson's disease

被引:25
作者
Martin, FL [1 ]
Williamson, SJM [1 ]
Paleologou, KE [1 ]
Allsop, D [1 ]
El-Agnaf, OMA [1 ]
机构
[1] Univ Lancaster, IENS, Dept Biol Sci, Lancaster LA1 4YQ, England
关键词
Parkinson's disease; DNA single-strand breaks; Fe(II); alpha-synuclein; Comet assay; comet tail length; reactive oxygen species; environmental causation;
D O I
10.2174/0929866043407138
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lesions known as Lewy bodies (LBs) and Lewy neurites (LNs) characterise brains of Parkinson's disease (PD) patients. Intracellular aggregation of alpha-synuclein (alpha-syn) appears to play a key role in the generation of LBs and LNs. Such aggregation in the presence of redox metals may initiate Fenton reaction-mediated generation of reactive oxygen species (ROS). ROS thus generated may result in cytotoxic mechanisms such as the induction of DNA single-strand breaks.
引用
收藏
页码:229 / 237
页数:9
相关论文
共 71 条
  • [1] Mice lacking α-synuclein display functional deficits in the nigrostriatal dopamine system
    Abeliovich, A
    Schmitz, Y
    Fariñas, I
    Choi-Lundberg, D
    Ho, WH
    Castillo, PE
    Shinsky, N
    Verdugo, JMG
    Armanini, M
    Ryan, A
    Hynes, M
    Phillips, H
    Sulzer, D
    Rosenthal, A
    [J]. NEURON, 2000, 25 (01) : 239 - 252
  • [2] Baba M, 1998, AM J PATHOL, V152, P879
  • [3] Buchman VL, 1998, MOL BIOL+, V32, P485
  • [4] A broken α-helix in folded α-synuclein
    Chandra, S
    Chen, XC
    Rizo, J
    Jahn, R
    Südhof, TC
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (17) : 15313 - 15318
  • [5] Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease:: Implications for pathogenesis and therapy
    Conway, KA
    Lee, SJ
    Rochet, JC
    Ding, TT
    Williamson, RE
    Lansbury, PT
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (02) : 571 - 576
  • [6] Kinetic stabilization of the α-synuclein protofibril by a dopamine-α-synuclein adduct
    Conway, KA
    Rochet, JC
    Bieganski, RM
    Lansbury, PT
    [J]. SCIENCE, 2001, 294 (5545) : 1346 - 1349
  • [7] Wild-type but not Parkinson's disease-related Ala-53 → Thr mutant α-synuclein protects neuronal cells from apoptotic stimuli
    da Costa, CA
    Ancolio, K
    Checler, F
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (31) : 24065 - 24069
  • [8] Stabilization of α-synuclein secondary structure upon binding to synthetic membranes
    Davidson, WS
    Jonas, A
    Clayton, DF
    George, JM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (16) : 9443 - 9449
  • [9] Review:: Formation and properties of amyloid-like fibrils derived from α-synuclein and related proteins
    El-Agnaf, OMA
    Irvine, GB
    [J]. JOURNAL OF STRUCTURAL BIOLOGY, 2000, 130 (2-3) : 300 - 309
  • [10] α-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma
    El-Agnaf, OMA
    Salem, SA
    Paleologou, KE
    Cooper, LJ
    Fullwood, NJ
    Gibson, MJ
    Curran, MD
    Court, JA
    Mann, DMA
    Ikeda, S
    Cookson, MR
    Hardy, J
    Allsop, D
    [J]. FASEB JOURNAL, 2003, 17 (11) : 1945 - +